Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
about
Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"T cell responses in hepatitis C virus infection: historical overview and goals for future researchFull-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered ChimpanzeesImpaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionMultispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceEvidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infectionCellular immune responses against persistent hepatitis C virus: gone but not forgottenRelation between viral fitness and immune escape within the hepatitis C virus proteaseViral Sequence Evolution in Acute Hepatitis C Virus InfectionCD8 Epitope Escape and Reversion in Acute HCV InfectionCellular immune selection with hepatitis C virus persistence in humansAnalysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population LevelAcute hepatitis C virus infection: A chronic problemCell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing CellsComparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 ResponsivenessHepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVHepatitis C virus immune escape via exploitation of a hole in the T cell repertoirePrevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell DeterminantInfluence of host resistance on viral adaptation: hepatitis C virus as a case studyThe broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine designAdaptive immune responses in acute and chronic hepatitis C virus infectionGenetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.High throughput T epitope mapping and vaccine developmentProtective immunity against hepatitis C: many shades of gray.Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humansComparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyDCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.Profiling humoral immune responses to P. falciparum infection with protein microarraysStrong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.HCV immunology--death and the maiden T cell.A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct.High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis BAnti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
P2860
Q24645078-E95140E2-1DBE-453E-A3C0-EE36F5F250BAQ24814428-4CEFCDD4-3F90-4636-BBE7-74F04DDF336FQ27003510-45782C72-C60B-4A72-A406-767C973C8B7DQ27472170-BA282A39-63EE-4AD1-AD8D-DB365B7286F9Q27473402-9820822A-56B7-45BB-AE10-9D13C27CDC66Q27477797-9EAE876D-3578-4895-AD07-CBED21C79077Q27477974-D2F7B016-ADAE-4A7A-95C1-715B5ECCE056Q27478105-F39FE745-5612-4740-AD0E-C64789B702AAQ27478326-17329F89-7B86-4AE8-83A0-F0CB6CC6615FQ27478333-E69E1CC8-55F2-4A43-B5B9-FE19ADCAAA77Q27484985-A749840A-5636-48E7-9B74-EE1C867CB119Q27485189-95FCB73A-6BFB-49C2-B4BD-1D795619A378Q27485219-48AF41BC-CD0E-47FD-BD12-BDCBBB9C0355Q27485493-6992F266-1933-4E5F-B9E1-FB4385D0DFF2Q27485639-92080634-1C1F-4C23-81FF-7F1D90289A20Q27485758-651DDAFA-F4D5-4B8D-A6ED-B227176D2F62Q27487966-E5757FC0-D08C-40B8-A6A4-68A7934987C8Q27488816-7C15E1FD-2094-4B12-9BF3-384B83AC0E80Q27489598-479DBA0C-F897-4304-81BD-D0DC8E3348C5Q27652640-DB33F7FF-E688-4EC1-ABB5-2B6184D8847FQ28087595-13CB167F-1732-4DC7-B1F7-FAD5569B52D3Q28602408-BA6939B5-DB21-4715-BC47-4514FD0F620BQ29619722-EB1BF1C3-249A-4AC9-A845-A4BA750D096CQ31112300-2A04452A-A984-4A26-A091-7521155FC3F7Q33628719-59B3AF4A-C89E-4C1A-966A-A47695A987ABQ33759224-D3600AB4-FC6A-4C5A-83A0-0A3FCE6DB72DQ33826033-92E149EF-EBD6-4481-ACB1-8CBE4B6BAE24Q33987526-EC034E57-4C3D-461D-AEC3-9346B2C6A3EBQ34120848-605266DC-FEC8-4306-A117-C6090D427D9FQ34151071-D2F16C31-C4F9-4F01-BB8D-D2603B6A4588Q34305417-FA464F03-5430-4A71-9B2E-0BB86537BDFDQ34468117-5865FE39-DAA4-4940-AED9-FD7836FE4F0FQ34493947-59FA7AB1-90DE-45F2-97D6-1A985CF95B00Q34495128-103476DD-D444-4E5F-8500-A0A5619375AFQ34764025-5AB108BE-367E-4CE4-931A-1525CBD3119AQ35091469-BEFF2860-CD26-4629-A4EF-4B23228D0DC5Q35122498-5C2C5BAA-1BF7-44DE-B276-409262C68B58Q35489009-9B4FD5E9-1CC1-4098-8581-060F2F87DD18Q35597143-BCF76DB9-B26C-418B-B80C-D9B7961DB142Q35673342-0E6FA7E6-0CDA-45D7-99D0-DD5972A87F91
P2860
Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
description
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2002-06)
@fr
articolo scientifico (pubblicato il 2002-06)
@it
artigo científico (publicado na 2002-06)
@pt
artículu científicu espublizáu en 2002
@ast
im Juni 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2002)
@en
vedecký článok (publikovaný 2002-06)
@sk
videnskabelig artikel (udgivet 2002-06)
@da
name
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@ast
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@en
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@nl
type
label
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@ast
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@en
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@nl
prefLabel
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@ast
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@en
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@nl
P2093
P2860
P50
P3181
P1433
P1476
Comprehensive Analysis of CD8+ ...... iple Unpredicted Specificities
@en
P2093
Arthur Y Kim
Cheryl L Day
Deborah R Purkis
Georg M Lauer
Markus Reiser
Michaela Lucas
Tam N Nguyen
P2860
P304
P3181
P356
10.1128/JVI.76.12.6104-6113.2002
P577
2002-06-01T00:00:00Z